Conclusion
The presence of resistant pneumococcal organisms has become a major problem in the world today. These organisms are responsible for changing the methodology required for susceptibility testing and for the newly proposed guidelines for resistance. These newly proposed MICs are still under consideration because of the limited data used for their establishment. The treatment of resistant pneumococcal infections outside of the central nervous system is not yet well standardized. Central nervous system infections should be approached with care and a knowledge of current recommendations for their therapy. We expect changes in the recommendations for therapy over the coming years until a standardized approach can be established.
References
Adams, W. G., Deaver, K. A., Cochi, S. L., Plikaytis, B. D., Zell, E. R., Broome, C. V., Wenger, J. D. Decline of childhoodHaemophilus influenzae type b (HIB) disease in the Hib vaccine era. JAMA 269 (1993) 221–226.
Hansman, D., Bullen, M. M. A resistantPneumococcus. Lancet ii (1967) 264–265.
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Feiman, I., Miller, G. B., Witcomb, M. A., Issacson, M., Ward, J. I., Austrian, R. Emergence of multiply resistant pneumococci. N. Engl. J. Med. 299 (1978) 735–740.
Macias, E. A., Mason, E. O. Jr., Ocera, H. Y., LaRocco, M. T. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains ofStreptococcus pneumoniae. J. Clin. Microbiol. 32 (1994) 430–432.
National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically — third edition; approved standard. NCCLS document M7-A3 (ISBN 1-56238-209-8). NCCLS, Villanova, Pa 1993, pp. 17–20.
Jorgensen, J. H., Ferraro, M. J., McElmeel, M. L., Spargo, J., Swenson, J. M., Tenover, F. C. Detection of penicillin and extended-spectrum cephalosporin resistance amongStreptococcus pneumoniae clinical isolates by the use of the E test. J. Clin. Microbiol. 32 (1994) 159–163.
Friedland, I. R., Shelton, S., McCracken, G. H. Jr Screening for cephalosporin-resistantStreptococcus pneumoniae with the Kirby-Bauer disk susceptibility test. J. Clin. Microbiol. 31 (1993) 1619–1621.
Spratt, B. G. Resistance to antibiotics mediated by target alterations. Science 264 (1994) 388–393.
Zighelboim, S., Tomasz, A. Penicillin-binding protein of multiply antiobiotic resistant South African strains ofStreptococcus pneumoniae. Antimicrob. Agents Chemother. 17 (1980) 434–442.
Malouin, F., Bryan, L. E. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrob. Agents Chemother. 30 (1986) 1–5.
Dowson, C. G., Coffey, T. J., Kell, C., Whiley, R. A. Evolution of penicillin resistance inStreptococcus pneumoniae; the role ofStreptococcus mitis in the formation of a low affinity PBP 2B inS. pneumoniae. Mol. Microbiol. 9 (1993) 635–643.
Dowson, C. G., Hutchinson, A., Woodford, N., Johnson, A. P., George, R. C., Spratt, B. G. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains ofStreptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 87 (1990) 5858–5862.
Chesney, P. J. The escalating problem of antimicrobial resistance inStreptococcus pneumoniae. Am. J. Dis. Child 146 (1992) 912–916.
Munoz, R., Coffey, T. J., Daniels, M., Dowson, C. G., Laible, G., Casal, J., Hakenbeck, R., Jacobs, M., Musser, J. M., Spratt, B. G., Tomasz, A. Intercontinental spread of a multiresistant clone of serotype 23FStreptococcus pneumoniae. J. Infect. Dis. 164 (1991) 302–306.
Munoz, R., Dowson, C. G., Daniels, M., Coffey, T. J., Martin, C., Hakenbeck, R., Spratt, B. G. Genetics of resistance to third-generation cephalosporins in clinical isolates ofStreptococcus pneumoniae. Mol. Microbiol. 6 (1992) 2461–2465.
Hakenbeck, R., Tornette, S., Adkinson, N. F. Interaction of non-lytic beta-lactams with penicillin-binding proteins inStreptococcus pneumoniae. J. Gen. Microbiol. 133 (1987) 755–760.
Fenoll, A., Bourgon, C. M., Munoz, R., Vicioso, D., Casal, J. Serotype distribution and antimicrobial resistance ofStreptococcus pneumoniae isolates causing systemic infections in Spain, 1979–1989. Rev. Infect. Dis. 13 (1991) 56–60.
Linares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F., Viladrich, P. F., Martin, R. Trends in antimicrobial resistance of clinical isolates ofStreptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clin. Infect. Dis. 15 (1929) 99–105.
Geslin, P., Buu-Hoi, A., Fremaux, A., Acar, J. F. Antimicrobial resistance inStreptococcus pneumoniae: an epidemiological survey in France, 1970–1990. Clin. Infect. Dis. 15 (1992) 95–98.
Reinert, R. R., Queck, A., Kaufhold, A., Kresken, M., Lutticken, R. Antibiotic sensitivity ofStreptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany. Infection 22 (1994) 113–114.
Marton, A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin. Infect. Dis. 15 (1992) 106–111.
Millar, M., Grover, M., Osbourne, F., Antoniou, A. Control of antibiotic resistantStreptococcus pneumoniae in Romaina [letter]. Lancet 338 (1991) 323.
Friedland, I. R., Klugman, K. P. Antibiotic-resistant pneumococcal disease in South African children. Am. J. Dis. Child 146 (1992) 920–923.
Bogaerts, J., Lepage, P., Taelman, H., Rouvroy, D., Batungwanayo, J., Kestelyn, P., Hitimana, D. G., Van de Perre, P., Vandepitte, J., Verbist, L., Verhaegen, J. Antimicrobial susceptibility and serotype distribution ofStreptococcus pneumoniae from Rwanda. J. Infect. 27 (1993) 157–168.
Hussain Qadri, S. M., Kroschinsky, R. Prevalence of pneumococci with increased resistance to penicillin in Saudi Arabia. Ann. Trop. Med. Parasitol. 85 (1991) 259–262.
Sessegolo, J. F., Levin, A. S. S., Levy, C. E., Asensi, M., Facklam, R. R., Teixeira, L. M. Distribution of serotypes and antimicrobial resistanceStreptococcus pneumoniae strains isolated in Brazil from 1988 to 1992. J. Clin. Microbiol. 32 (1994) 906–911.
Breiman, R. F., Butler, J. C., Tenover, F. C., Elliot, J. A., Facklam, R. R. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271 (1994) 1831–1835.
Welby, P. L., Keller, D. S., Cromien, J. L., Tebas, P., Storch, G. A. Resistance to penicillin and non-beta-lactam antibiotics ofStreptococcus pneumoniae at a children's hospital. Pediatr. Infect. Dis. J. 13 (1994) 281–287.
Centers for Disease Control and Prevention Drug resistantStreptococcus pneumoniae — Kentucky and Tennessee, 1993. MMWR 43 (1994) 23–31.
Koornhof, H. J., Wasas, A., Klugman, K. Antimicrobial resistance inStreptococcus pneumoniae: a South African perspective. Clin. Infect. Dis. 15 (1992) 84–94.
Thompson, J. W., Lewno, M. J., Schutze, G. E. Antibiotic resistant pneumococcal disease at Arkansas Children's Hospital, 1990 to 1993. Pediatr. Infect. Dis. J. 13 (1994) 408–409.
Doern, G. V. Commentary:S. pneumoniae antibiotic resistance — an emerging problem. Infect. Dis. Clin. Prac. 3 (1994) 110–113.
Thornsberry, C., Brown, S. D., Yee, Y. C., Bouchillon, S. K., Marler, J. K., Rich, T. Increasing penicillin resistance inStreptococcus pneumoniae in the U. S.: effect on susceptibility to oral cephalosporins. Infect. Med. 10D (Suppl.) (1993) 15–24.
Nelson, C. T., Mason, E. O. Jr., Kaplan, S. L. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistantStreptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13 (1994) 585–589.
Appelbaum, P. C., Scragg, J. N., Bowen, A. J., Bhamjee, A., Hallett, A. F., Cooper, R. C. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet ii (1977) 995–997.
Pallares, R., Guidol, F., Linares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., Viladrich, P. F. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N. Engl. J. Med. 317 (1987) 18–22.
Sloas, M. M., Barrett, F. F., Chesney, P. J., English, B. K., Hill, B. C., Tenover, F. C., Leggiadro, R. J. Cephalosporin treatment failure in penicillin- and cephalosporin-resistantStreptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11 (1992) 662–666.
Jacobs, M. R. Treatment and diagnosis of infections caused by drugresistantStreptococcus pneumoniae. Clin. Infect. Dis. 15 (1992) 119–127.
Viladrich, P. F., Gudiol, F., Linares, J., Rufi, G., Ariza, J., Pallares, R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am. J. Med. 84 (1988) 839–846.
Tan, T. Q., Schutze, G. E., Mason, E. O. Jr., Kaplan, S. L. Antibiotic therapy and acute outcome of meningitis due toStreptococcus pneumoniae considered intermediately susceptible to broad spectrum cephalosporins. Antimicrob. Agents Chemother. 38 (1994) 918–923.
American Academy of Pediatrics, Committee on Infectious Diseases: Report of the Committee on Infectious Diseases. 23rd edition. Elk Grove Village, IL, American Academy of Pediatrics (1994) 558–559.
Paris, M. M., Hickey, S. M., Uscher, M. I., Shelton, S., Olsen, K. D., McCracken, G. H. Jr. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 38 (1994) 1320–1324.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schutze, G.E., Kaplan, S.L. & Jacobs, R.F. Resistant pneumococcus: A worldwide problem. Infection 22, 233–237 (1994). https://doi.org/10.1007/BF01739904
Issue Date:
DOI: https://doi.org/10.1007/BF01739904